Three methoxy‐substituted diethyl 4‐­phenyl‐2,6‐di­methyl‐1,4‐di­hydro­pyridine‐3,5‐di­carboxyl­ate compounds

Diethyl 4‐(2,5‐di­methoxy­phenyl)‐2,6‐di­methyl‐1,4‐di­hydro­pyridine‐3,5‐di­carboxyl­ate, C₂₁H₂₇NO₆, (I), diethyl 4‐(3,4‐di­methoxy­phenyl)‐2,6‐di­methyl‐1,4‐di­hydro­pyridine‐3,5‐di­carboxyl­ate, C₂₁H₂₇NO₆, (II), and diethyl 2,6‐di­methyl‐4‐(3,4,5‐tri­methoxy­phenyl)‐1,4‐di­hydro­pyridine‐3,5‐di­carboxyl­ate, C₂₂H₂₉NO₇, (III), crystallize with hydrogen‐bonding networks involving the H atom bonded to the N atom of the 1,4‐di­hydro­pyridine ring and carbonyl O atoms in (I) and (II). Unusually, (III) shows O atoms of methoxy groups serving as hydrogen‐bond acceptors.     

Resolution of (S,S)‐4‐(2,2,4‐tri­methyl­chroman‐4‐yl)­phenyl camphanate and its 4‐chromanyl epimer by crystallization

Dianin's compound (4‐p‐hydroxy­phenyl‐2,2,4‐tri­methyl­chroman) has been resolved by crystallization of the (S)‐(−)‐camphanic esters (S,S)‐ and (R,S)‐4‐(2,2,4‐tri­methyl­chroman‐4‐yl)­phenyl 4,7,7‐tri­methyl‐3‐oxo‐2‐oxabi­cyclo[2.2.1]heptane‐1‐carboxyl­ate, both C₂₈H₃₂O₅, from 2‐methoxy­ethanol, yielding the pure S,S diastereomer. The relative stereochemistry of both diastereomers has been determined by X‐ray crystallography, from which the absolute stereochemistry could be deduced from the known configuration of the camphanate moiety. The crystallographic conformations have been analysed, including the 1:1 disorder of the R,S diastereomer.     

Potassium 3‐cyano‐4‐(dicyanomethylene)‐5‐oxo‐4,5‐dihydro‐1H‐pyrrol‐2‐olate

The crystal structure of the title potassium salt, K⁺·C₈HN₄O₂⁻, of the organic anion 3‐cyano‐4‐(di­cyano­methyl­ene)‐5‐oxo‐4,5‐di­hydro‐1H‐pyrrol‐2‐olate shows that the di­cyano­methyl­ene moiety is able to accept an electron in the same way as does tetra­cyano­ethyl­ene, to yield the novel product. The organic anion is nearly planar, with deviations caused by steric crowding among the exocyclic cyano groups. The K⁺ cations lie within tricapped trigonal prisms that stack to form channels. The three‐dimensional structure is completed by the formation of hydrogen‐bonded chains by the anions.     

Bis(2,5‐dimethoxy‐4‐methylphenyl)methane and bis(2,5‐dimethoxy‐3,4,6‐trimethylphenyl)methane

Bis(2,5‐di­methoxy‐4‐methyl­phenyl)­methane, C₁₉H₂₄O₄, (IIa), was obtained and characterized as a minor product from the reaction of tolu­hydro­quinone di­methyl ether (1,4‐dimethoxy‐2‐methylbenzene) with N‐(hydroxy­methyl)­tri­fluoro­acet­amide. Similarly, bis(2,5‐di­methoxy‐3,4,6‐tri­methyl­phenyl)­methane, C₂₃H₃₂O₄, (IIb), was prepared from the corresponding reaction of tri­methyl­hydro­quinone di­methyl ether (2,5‐dimethoxy‐1,3,4‐trimethylbenzene). The mol­ecules of (IIa) and (IIb) each lie on a twofold axis passing through the methyl­ene group. The dihedral angle between the planar phenyl rings is 73.4 (1)° in (IIa) and 77.9 (1)° in (IIb). The external bond angles around the bridging methyl­ene group are 116.6 (2) and 117.3 (2)° for (IIa) and (IIb), respectively. In (IIa), the methoxy substituents lie in the plane of the ring and are conjugated with the aromatic system, whereas in (IIb), they are almost perpendicular to the phenyl ring and are positioned on opposite sides.     

N‐(2‐Carboxy­benzoyl)‐l‐leucine methyl ester

The title compound (with the systematic name 2‐{[(1S)‐1‐(methoxy­carbonyl)‐3‐methyl­butyl]amino­carbonyl}benzoic acid), C₁₅H₁₉NO₅, crystallizes in the monoclinic space group P2₁, with two independent mol­ecules per asymmetric unit. The most notable difference between the two mol­ecules is in the dihedral angles between the planes of the carboxyl group and the benzene ring, which are 3.5 (3) and 25.7 (1)°. This difference may account for the fact that two competing reactions are observed in aqueous solution, namely cyclization to form the imide N‐phthaloyl­leucine and hydrolysis of N‐(2‐carboxy­benzoyl)‐l ‐leucine methyl ester to phthalic acid and leucine.     

1‐[4‐(Methyl­sulfonyl)­phenyl]‐5‐phenyl‐1H‐pyrazole derivatives

Three related compounds containing a pyrazole moiety with vicinal phenyl rings featuring a methyl­sulfonyl substituent are described, namely 3‐methyl‐1‐[4‐(methyl­sulfonyl)­phenyl]‐5‐phenyl‐1H‐pyrazole, C₁₇H₁₆N₂O₂S, ethyl 1‐[4‐(methyl­sul­fonyl)­phenyl]‐5‐phenyl‐1H‐pyrazole‐3‐carboxyl­ate, C₁₉H₁₈N₂O₄S, and 1‐[4‐(methyl­sulfonyl)­phenyl]‐3‐[3‐(morpholino)­phenoxy­methyl]‐5‐phenyl‐1H‐pyrazole, C₂₇H₂₇N₃O₄S. The design of these compounds was based on celecoxib, a selective cyclo­oxy­genase‐2 (COX‐2) inhibitor, in order to study the influence of various substituents on COX‐2 and 5‐lipoxy­genase (5‐LOX) inhibition.     

A new optically pure half‐sandwich Cp–Ru diphosphine complex with a chiral metal centre, (S)‐Ru(η5‐C5H5)(EPHOS)Cl {EPHOS is (+)‐(1R,2S)‐2‐[(diphenylphosphino)methylamino]‐1‐phenylpropyl diphenylphosphinite}

The crystal structure of the title compound, chloro(η⁵‐cyclopenta­dienyl){(1R,2S)‐2‐[(di­phenyl­phosphino)­methyl­amino]‐1‐phenyl­propyl di­phenyl­phosphinite‐κ²P,P′}ruthenium(II), [Ru(C₅H₅)Cl(C₃₄H₃₃NOP₂)], is reported. The pseudo‐octa­hedral complex is chiral and the configuration at the Ru atom is S. The seven‐membered metallacycle adopts a boat‐like conformation.     

{(E)‐ and {(Z)‐2‐[α,β‐bis­(methoxy­carbonyl)­vinyl]­cyclo­pentadien‐1‐yl­idene}tri­phenyl­phospho­rane

The Ramirez yl­ide undergoes electrophilic substitution with di­alkyl acetyl­ene­di­carboxyl­ates, yielding a mixture of the Z and E adducts. The crystal structure analyses of the two adducts formed using di­methyl­acetyl­ene, viz. di­methyl (E)‐ and (Z)‐1‐[2‐(tri­phenyl­phospho­ranyl­idene)­cyclo­pentadien‐1‐yl]­ethyl­ene­di­carboxyl­ate, both C₂₉H₂₅O₄P, explain an unusual chemical shift observed for the vinyl H atom of the Z adduct, which had previously precluded a definitive assignment of the isomers. In addition, the structures explain why only one of the isomers reacts further with acetyl­ene esters to produce azulenes with a rare substitution pattern.     

Two 5‐oxa‐2,6‐diazaspiro[3.4]octan‐1‐one derivatives from the [3+2] cyclo­addition of methylenelactams with nitrones

The two title 5‐oxa‐2,6‐di­aza­spiro­[3.4]­octan‐1‐one adducts, 7‐benzoyl‐2‐(4‐methoxy­phenyl)‐6‐phenyl‐5‐oxa‐2,6‐di­aza­spiro­[3.4]­octan‐1‐one, C₂₅H₂₂N₂O₄, (III), and 6‐tert‐butyl‐2‐(4‐methyl­phenyl)‐7‐phenyl‐5‐oxa‐2,6‐di­aza­spiro­[3.4]­octan‐1‐one, C₂₂H₂₆N₂O₂, (IV), were obtained from a stereospecific [3+2] 1,3‐cyclo­addition of 3‐methyl­ene azetidin‐2‐ones as dipolaro­philes with nitro­nes. The lactam ring is conjugated with the p‐­methoxy­phenyl or p‐methyl­phenyl moiety. The envelope conformations of the isoxazolidine rings in (III) and (IV) are different, leading the substituents to be pseudo‐axial in (III) and pseudo‐equatorial in (IV).     

Two new conformationally restricted 4,5‐dihydroxynorvaline analogues with a norbornane skeleton

The structures of two conformationally restricted 4,5‐di­hydroxy­norvaline analogues with a norbornane skeleton, namely methyl (1S,2S,3R,4R)‐2‐benz­amido‐3‐(1,2‐di­hydroxy­ethyl)­bi­cyclo[2.2.1]­heptane‐2‐carboxyl­ate, C₁₈H₂₃NO₅, and methyl (1R,2S,3R,4S)‐2‐benz­amido‐3‐(1,2‐di­hydroxy­ethyl)­bi­cyclo[2.2.1]­heptane‐2‐carboxyl­ate, C₁₈H₂₃NO₅, exhibit a conformation in the helical region of the ?,ψ map but their handedness is opposite. In both cases, the torsion angles (χ^1,1) giving the relative orientation of the 1,2‐di­hydroxy­ethyl group of the amino acid side chain and the benz­amide group of the peptide chain indicate that these groups adopt a nearly eclipsed conformation. Both compounds show a complex hydrogen‐bonding pattern.     

Diphenyl(2‐thioxo‐1,3‐dithiole‐4,5‐di­thiolato‐S,S′)plumbane at 295 K and diphenyl(2‐thioxo‐1,3‐dithiole‐4,5‐di­thiolato‐S,S′)stannane at 150 K

Molecules of di­phenyl(2‐thio­xo‐1,3‐di­thiole‐4,5‐di­thiol­ato‐S,S′)­plumbane, [Pb(C₃S₅)(C₆H₅)₂], are linked into sheets via two intermolecular Pb?S_thione interactions of 3.322 (4) and 3.827 (4) Å; the Pb centre has a distorted octahedral geometry. In contrast, mol­ecules of ­di­phenyl(2‐thio­xo‐1,3‐di­thiole‐4,5‐di­thiol­ato‐S,S′)­stannane, [Sn(C₃S₅)(C₆H₅)₂], are linked into chains via a single intermolecular Sn—S_thione interaction of 2.8174 (9) Å; the Sn centre has a distorted trigonal‐bipy­ramidal geometry.     

Self‐assembly of 2‐pivaloyl‐6‐chloro­pterin

In the title compound, N‐(6‐chloro‐4‐oxo‐3,4‐di­hydro­pteridin‐2‐yl)­‐2,2‐di­methyl­propan­amide, C₁₁H₁₂ClN₅O₂, the rings in the pterin moiety are planar. The amide carbonyl O atom is in syn‐periplanar conformation while the C—N—C—C propanamide linkage is antiperiplanar. The N—H?N and N—H?O intermolecular hydrogen bonds transform the mol­ecules into infinite chains.     

Tetrakis(μ‐2,3‐dimethoxybenzoato)bis[(2,2′‐bipyridine)(2,3‐dimethoxybenzoato)lanthanum(III)]

The title compound, tetrakis(μ‐2,3‐di­methoxy­benzoato)‐κ⁴O:O′;κ⁶O,O′:O′‐bis[(2,2′‐bi­pyridine‐N,N′)(2,3‐di­methoxy­benzoato‐O,O′)lanthanum(III)], [La₂(2,3‐DMOBA)₆(2,2′‐bpy)₂], where 2,3‐DMOBA is 2,3‐di­methoxy­benzoate (C₉H₉O₄) and 2,2′‐bpy is 2,2′‐bi­pyridine (C₁₀H₈N₂), is a dimer with a centre of inversion between the La atoms bridged by four carboxyl­ate ligands. The central La atom is ennea‐coordinated and has a distorted monocapped square‐antiprism geometry.     

Two isomeric di­deoxy­nucleosides

We have synthesized two isomeric di­deoxy­nucleosides. 4(S)‐(6‐Amino‐9H‐purin‐9‐yl)‐3‐methyl­ene‐2,3,4,5‐tetra­hydrofuran‐2(S)‐yl­methanol, C₁₁H₁₃N₅O₂, is an analogue of the anti‐HIV compound (S,S)‐isodi­deoxy­adenosine (isoDDA) with an exocyclic methyl­ene group and is found to be anti‐HIV inactive. The solid‐state comformation is very similar to that of isoDDA. 4(S)‐(6‐Amino‐3H‐purin‐3‐yl)‐3‐methyl­ene‐2,3,4,5‐tetra­hydro­furan‐2(S)‐ylmethanol, C₁₁H₁₃N₅O₂, has an isomeric arrangement of the carbohydrate and base moieties, as confirmed by the crystal structure analysis. The asymmetric unit contains two independent mol­ecules that differ in conformations at the sugar moiety.     

The conversion of a pyrrole trimer derivative into a 4,5,6,7‐tetra­hydro‐4‐­(pyrrol‐2‐yl)indol‐7‐yl­tosyl­aminoindole

Vilsmeier formyl­ation of trans‐1‐(4‐methyl­phenyl­sulfonyl)‐2,5‐bis(pyrrol‐2‐yl)­pyrrolidine leads to cleavage of the central ring then a reclosure resulting in the formation of trans‐N‐[2‐formyl‐4‐(5‐formyl­pyrrol‐2‐yl)‐4,5,6,7‐tetra­hydro­indol‐7‐yl]­toluene­sulfon­amide, C₂₁H₂₁N₃O₄S.     

1d‐3,4‐Di‐O‐(di­phenyl­methylphos­pho­nio)‐1,2,5,6‐tetra‐O‐methyl‐chiro‐inositol diiodide

The title compound, 3,4,5,6‐tetra­methoxy­cyclo­hexane‐1,2‐diyl­dioxy­bis­(methyl­di­phenyl­phospho­nium) diiodide, C₃₆­H₄₄­O₆­P₂²⁺·­2I^?, was prepared from a New Zealand natural product, d ‐chiro‐inositol, in order to develop new catalytic metal complexes. The inositol ring retains its usual chair conformation with only minor perturbations caused by the bound di­phenyl­methyl­phosphines. Crystal‐packing forces are provided by C—H?I cation–anion interactions.     

Precursor of a β‐lactamase inhibitor: allyl (4S,8S,9R)‐10‐[(E)‐ethyl­idene]‐4‐methoxy‐11‐oxo‐1‐aza­tri­cyclo­[7.2.0.03,8]­undec‐2‐ene‐2‐carboxyl­ate

The molecular structure of the title tricyclic compound, C₁₇H₂₁NO₄, which is the immediate precursor of a potent synthetic inhibitor {Lek157: sodium (8S,9R)‐10‐[(E)‐ethyl­idene]‐4‐methoxy‐11‐oxo‐1‐aza­tri­cyclo­[7.2.0.0^3,8]­undec‐2‐ene‐2‐carboxyl­ate} with remarkable potency, provides experimental evidence for the previously modelled relative position of the fused cyclo­hexyl ring and the carbonyl group of the β‐lactam ring, which takes part in the formation of the initial tetrahedral acyl–enzyme complex. In this hydro­phobic mol­ecule, the overall geometry is influenced by C—H?O intramolecular hydrogen bonds [3.046 (4) and 3.538 (6) Å, with corresponding normalized H?O distances of 2.30 and 2.46 Å], whereas the mol­ecules are interconnected through intermolecular C—H?O hydrogen bonds [3.335 (4)–3.575 (5) Å].     

tert‐Butyl (6S)‐4‐hydroxy‐6‐isobutyl‐2‐oxo‐1,2,5,6‐tetra­hydropyridine‐1‐carboxyl­ate and tert‐butyl (4R,6S)‐4‐hydroxy‐6‐iso­butyl‐2‐oxopiperidine‐1‐carboxyl­ate

X‐ray studies reveal that tert‐butyl (6S)‐6‐iso­butyl‐2,4‐dioxo­piperidine‐1‐carboxyl­ate occurs in the 4‐enol form, viz. tert‐butyl (6S)‐4‐hydroxy‐6‐iso­butyl‐2‐oxo‐1,2,5,6‐tetra­hydropyri­dine‐1‐carboxyl­ate, C₁₄H₂₃NO₄, when crystals are grown from a mixture of di­chloro­methane and pentane, and has an axial orientation of the iso­butyl side chain at the 6‐position of the piperidine ring. Reduction of the keto functionality leads predominantly to the corresponding β‐hydroxy­lated δ‐lactam, tert‐butyl (4R,6S)‐4‐hydroxy‐6‐iso­butyl‐2‐oxo­piperidine‐1‐car­boxyl­ate, C₁₄H₂₅NO₄, with a cis configuration of the 4‐hydroxy and 6‐iso­butyl groups. The two compounds show similar molecular packing driven by strong O—H⋯O=C hydrogen bonds, leading to infinite chains in the crystal structure.     

4‐Methyl‐2‐[N‐(3,4‐methyl­ene­dioxy­benzyl­idene)hydrazino]­thia­zole and its reduction product, 4‐methyl‐2‐[N‐(3,4‐methyl­ene­dioxybenzyl­idene)hydrazono]‐4,5‐di­hydro­thia­zole

The crystal structures of 4‐methyl‐2‐[N‐(3,4‐methyl­ene­dioxybenzyl­idene)hydrazino]­thia­zole, C₁₂H₁₁N₃O₂S, and its reduction product 4‐methyl‐2‐[N‐(3,4‐methyl­ene­dioxybenzyl­idene)hydrazono]‐4,5‐di­hydro­thia­zole, C₁₂H₁₃N₃O₂S, have been determined and compared. In the reduction product, the tautomer observed bears an H atom on the exocyclic N atom. Both compounds form hydrogen‐bonded dimers over centers of inversion.     

(1R,3S)‐1‐Mono­amido­camphoric acid

The title compound, (1S,3R)‐3‐carbamoyl‐2,2,3‐tri­methyl­cyclo­pentane‐1‐carboxyl­ic acid, C₁₀H₁₇NO₃, was synthesized and characterized by IR, EA, ES–MS (electrospray ionization mass spectra), ¹H NMR, ¹³C NMR and X‐ray diffraction techniques. The two independent mol­ecules form a two‐dimensional network via O—H⃛O and N—H⃛O hydrogen‐bonding interactions between their carbox­ylic acid and carbamoyl groups.